Literature DB >> 28978670

Sterol transfer, PI4P consumption, and control of membrane lipid order by endogenous OSBP.

Bruno Mesmin1, Joëlle Bigay1, Joël Polidori1, Denisa Jamecna1, Sandra Lacas-Gervais2, Bruno Antonny3.   

Abstract

The network of proteins that orchestrate the distribution of cholesterol among cellular organelles is not fully characterized. We previously proposed that oxysterol-binding protein (OSBP) drives cholesterol/PI4P exchange at contact sites between the endoplasmic reticulum (ER) and the trans-Golgi network (TGN). Using the inhibitor OSW-1, we report here that the sole activity of endogenous OSBP makes a major contribution to cholesterol distribution, lipid order, and PI4P turnover in living cells. Blocking OSBP causes accumulation of sterols at ER/lipid droplets at the expense of TGN, thereby reducing the gradient of lipid order along the secretory pathway. OSBP consumes about half of the total cellular pool of PI4P, a consumption that depends on the amount of cholesterol to be transported. Inhibiting the spatially restricted PI4-kinase PI4KIIIβ triggers large periodic traveling waves of PI4P across the TGN These waves are cadenced by long-range PI4P production by PI4KIIα and PI4P consumption by OSBP Collectively, these data indicate a massive spatiotemporal coupling between cholesterol transport and PI4P turnover via OSBP and PI4-kinases to control the lipid composition of subcellular membranes.
© 2017 The Authors.

Entities:  

Keywords:  Golgi apparatus; cholesterol; lipid‐transfer protein; membrane contact site; phosphatidylinositol 4‐phosphate

Mesh:

Substances:

Year:  2017        PMID: 28978670      PMCID: PMC5666618          DOI: 10.15252/embj.201796687

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  62 in total

1.  A human interactome in three quantitative dimensions organized by stoichiometries and abundances.

Authors:  Marco Y Hein; Nina C Hubner; Ina Poser; Jürgen Cox; Nagarjuna Nagaraj; Yusuke Toyoda; Igor A Gak; Ina Weisswange; Jörg Mansfeld; Frank Buchholz; Anthony A Hyman; Matthias Mann
Journal:  Cell       Date:  2015-10-22       Impact factor: 41.582

2.  A four-step cycle driven by PI(4)P hydrolysis directs sterol/PI(4)P exchange by the ER-Golgi tether OSBP.

Authors:  Bruno Mesmin; Joëlle Bigay; Joachim Moser von Filseck; Sandra Lacas-Gervais; Guillaume Drin; Bruno Antonny
Journal:  Cell       Date:  2013-11-07       Impact factor: 41.582

3.  Natural products reveal cancer cell dependence on oxysterol-binding proteins.

Authors:  Anthony W G Burgett; Thomas B Poulsen; Kittikhun Wangkanont; D Ryan Anderson; Chikako Kikuchi; Kousei Shimada; Shuichi Okubo; Kevin C Fortner; Yoshihiro Mimaki; Minpei Kuroda; Jason P Murphy; David J Schwalb; Eugene C Petrella; Ivan Cornella-Taracido; Markus Schirle; John A Tallarico; Matthew D Shair
Journal:  Nat Chem Biol       Date:  2011-08-07       Impact factor: 15.040

4.  The OSBP-related protein family in humans.

Authors:  M Lehto; S Laitinen; G Chinetti; M Johansson; C Ehnholm; B Staels; E Ikonen; V M Olkkonen
Journal:  J Lipid Res       Date:  2001-08       Impact factor: 5.922

5.  Phosphatidylinositol 4-kinase IIIbeta regulates the transport of ceramide between the endoplasmic reticulum and Golgi.

Authors:  Balázs Tóth; András Balla; Hui Ma; Zachary A Knight; Kevan M Shokat; Tamas Balla
Journal:  J Biol Chem       Date:  2006-09-26       Impact factor: 5.157

6.  OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activation.

Authors:  Ping-Yuan Wang; Jian Weng; Richard G W Anderson
Journal:  Science       Date:  2005-03-04       Impact factor: 47.728

7.  Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport.

Authors:  David E Sleat; Jennifer A Wiseman; Mukarram El-Banna; Sandy M Price; Lucie Verot; Michael M Shen; G Stephen Tint; Marie T Vanier; Steven U Walkley; Peter Lobel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

Review 8.  Inositol lipid regulation of lipid transfer in specialized membrane domains.

Authors:  Yeun Ju Kim; Maria-Luisa Guzman Hernandez; Tamas Balla
Journal:  Trends Cell Biol       Date:  2013-03-13       Impact factor: 20.808

Review 9.  Structural organization of the Golgi apparatus.

Authors:  Martin Lowe
Journal:  Curr Opin Cell Biol       Date:  2010-11-09       Impact factor: 8.382

10.  Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein.

Authors:  Jeroen R P M Strating; Lonneke van der Linden; Lucian Albulescu; Joëlle Bigay; Minetaro Arita; Leen Delang; Pieter Leyssen; Hilde M van der Schaar; Kjerstin H W Lanke; Hendrik Jan Thibaut; Rachel Ulferts; Guillaume Drin; Nina Schlinck; Richard W Wubbolts; Navdar Sever; Sarah A Head; Jun O Liu; Philip A Beachy; Maria A De Matteis; Matthew D Shair; Vesa M Olkkonen; Johan Neyts; Frank J M van Kuppeveld
Journal:  Cell Rep       Date:  2015-01-29       Impact factor: 9.423

View more
  48 in total

1.  Molecular and cellular dissection of the oxysterol-binding protein cycle through a fluorescent inhibitor.

Authors:  Tiphaine Péresse; David Kovacs; Mélody Subra; Joëlle Bigay; Meng-Chen Tsai; Joël Polidori; Romain Gautier; Sandy Desrat; Lucile Fleuriot; Delphine Debayle; Marc Litaudon; Van-Cuong Pham; Jérôme Bignon; Bruno Antonny; Fanny Roussi; Bruno Mesmin
Journal:  J Biol Chem       Date:  2020-02-19       Impact factor: 5.157

2.  Phosphatidylinositol 4,5-bisphosphate controls Rab7 and PLEKHM1 membrane cycling during autophagosome-lysosome fusion.

Authors:  Takashi Baba; Daniel J Toth; Nivedita Sengupta; Yeun Ju Kim; Tamas Balla
Journal:  EMBO J       Date:  2019-03-13       Impact factor: 11.598

3.  OSBP-related protein-2 (ORP2): a novel Akt effector that controls cellular energy metabolism.

Authors:  Henriikka Kentala; Annika Koponen; Helena Vihinen; Juho Pirhonen; Gerhard Liebisch; Zoltan Pataj; Annukka Kivelä; Shiqian Li; Leena Karhinen; Eeva Jääskeläinen; Robert Andrews; Leena Meriläinen; Silke Matysik; Elina Ikonen; You Zhou; Eija Jokitalo; Vesa M Olkkonen
Journal:  Cell Mol Life Sci       Date:  2018-06-12       Impact factor: 9.261

Review 4.  An equal opportunity collaboration between lipid metabolism and proteins in the control of membrane trafficking in the trans-Golgi and endosomal systems.

Authors:  Yaxi Wang; Carl J Mousley; Marta G Lete; Vytas A Bankaitis
Journal:  Curr Opin Cell Biol       Date:  2019-04-28       Impact factor: 8.382

Review 5.  Bridging the molecular and biological functions of the oxysterol-binding protein family.

Authors:  Antonietta Pietrangelo; Neale D Ridgway
Journal:  Cell Mol Life Sci       Date:  2018-03-13       Impact factor: 9.261

Review 6.  Cellular mechanisms of physicochemical membrane homeostasis.

Authors:  Robert Ernst; Stephanie Ballweg; Ilya Levental
Journal:  Curr Opin Cell Biol       Date:  2018-05-19       Impact factor: 8.382

Review 7.  Understanding phosphoinositides: rare, dynamic, and essential membrane phospholipids.

Authors:  Eamonn J Dickson; Bertil Hille
Journal:  Biochem J       Date:  2019-01-07       Impact factor: 3.857

8.  BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.

Authors:  Calvin J Chan; Roberta Le; Kaylan Burns; Khadra Ahmed; Etienne Coyaud; Estelle M N Laurent; Brian Raught; Paul Melançon
Journal:  Mol Cell Proteomics       Date:  2019-09-13       Impact factor: 5.911

9.  FFAT motif phosphorylation controls formation and lipid transfer function of inter-organelle contacts.

Authors:  Thomas Di Mattia; Arthur Martinet; Souade Ikhlef; Alastair G McEwen; Yves Nominé; Corinne Wendling; Pierre Poussin-Courmontagne; Laetitia Voilquin; Pascal Eberling; Frank Ruffenach; Jean Cavarelli; John Slee; Timothy P Levine; Guillaume Drin; Catherine Tomasetto; Fabien Alpy
Journal:  EMBO J       Date:  2020-10-30       Impact factor: 11.598

Review 10.  Novel roles of phosphoinositides in signaling, lipid transport, and disease.

Authors:  Gerald R V Hammond; John E Burke
Journal:  Curr Opin Cell Biol       Date:  2020-01-20       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.